Details for Patent: 5,382,573
✉ Email this page to a colleague
Summary for Patent: 5,382,573
Title: | Hormone preparation and method |
Abstract: | This invention is concerned with a contraceptive formulation and a method of contraception which employs a combination of estrogen and progestin and wherein a short period of relatively dominant estrogenic activity alternates with a short period of relatively dominant progestagenic activity. The invention also concerns a hormonal replacement formulation and method for use in menopausal or castrate women which employs a similar combination of estrogen and progestin. |
Inventor(s): | Casper; Robert F. (Toronto, CA) |
Assignee: | Jencap Research Ltd. (Toronto, CA) |
Application Number: | 08/143,055 |
Patent Claim Types: see list of patent claims | Composition; Compound; |
Drugs Protected by US Patent 5,382,573
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 5,382,573
International Family Members for US Patent 5,382,573
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 102484 | ⤷ Sign Up | |||
Austria | 209919 | ⤷ Sign Up | |||
Australia | 2276088 | ⤷ Sign Up | |||
Australia | 3044892 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |